A nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment cheaper for thousands of Australians. It is the first new depression medication ...

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...

Here’s how to ensure you’re getting the most out of your nasal spray. According to Dr Harish Bhatia, Founder Director of Rebreathe Clinic, New Delhi, “Many people use nasal sprays blindly ...

Nasal spray shows preclinical promise for treating traumatic brain injury. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250227125519.htm ...

He is the first patient to have permission from the U.S. Food and Drug Administration to try a nasal spray for moderate Alzheimer’s disease under the federal agency’s expanded access ...

The US Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as a standalone treatment for adults with major depressive disorder (MDD) who have not responded adequately ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant depression. This marks a significant advancement in depression treatment ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine ... at 11:59 p.m. PT. Apply today.

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first standalone therapy for adults suffering from major depressive disorder ...

Gulf Breeze, FL, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading innovator in sexual health solutions, is thrilled to announce the release of its groundbreaking PT-141 nasal spray ...